Manvi Arora
AI Spectrum contributor.
Latest Articles
Could Better Training Data Be the Key to Smarter AI Antibody Design?
Researchers are questioning whether AI antibody design tools fail not due to flawed models, but poor training data. Quality inputs may matter more than architecture.
AM Best to Share AI Adoption Survey Findings with Insurance Researchers
AM Best will present findings from its insurer AI adoption survey to Society of Insurance Research members, offering a rare industry-wide snapshot.
Children's National and Virginia Tech Expand Pediatric AI Partnership
The two institutions are deepening their collaboration to fast-track AI innovation in pediatric care, building on an existing research alliance.
AI Takes Center Stage in Travel Insurance at ITIC Americas 2026
Industry leaders gather to explore how AI can reshape the travel insurance customer journey, from claims to real-time support.
Insilico Medicine Heads to BIO 2026 to Display AI Drug Discovery Pipeline
Insilico Medicine will present its AI-powered drug discovery platform at BIO 2026, highlighting progress in generative biology and clinical candidates.
Empire AI Hits Early Milestone in Drug Discovery Research
The Empire AI consortium is showing real results in pharmaceutical research, signaling that state-backed AI initiatives can move fast when focused.
Kordata Launches AI Platform Built to Modernize Neural Clinical Trials
Kordata enters the clinical AI space with a neural-focused model designed to streamline trial processes. The startup targets a long-underserved gap in neuro research.
Patient Data Is the Missing Link in AI-Powered Drug Discovery
AI models in drug discovery fall short without real patient data. Researchers say closing this gap is critical to translating AI promise into clinical results.
AI Is Set to Transform Diagnostics Into Healthcare's Most Critical Layer
AI is reshaping diagnostics from a backend function into the central nervous system of modern healthcare, demanding serious attention from providers and investors alike.
How AI's Algorithmic Design Could Make or Break Financial Stability
New CEPR research examines how the structure of AI systems used in finance could amplify systemic risk or help contain it.
Incyte Partners With Edison to Build AI Models Through Drug Discovery Pipeline
Pharma firm Incyte has struck a deal with Edison to use drug discovery data for AI training, blending biotech research with machine learning development.
McCormick Backs AI Research Funding at Penn Biotech Labs Amid NSF Budget Chaos
Sen. McCormick visited Penn's AI-powered biotech facilities to champion federal AI investment, even as NSF faces significant funding disruption.